i2a SA
Montpellier
About i2a SA
Founded in 1998 by 3 Polytechnique engineers, Dominique Curel, Jean-Philippe Duvergé and Christian Curel, I2A is a diagnostic and medical informatics company. The company manufactures and markets instruments, software and reagents for microbiology laboratories and infection prevention services. I2A has developed unique know-how in the field of microbiology by combining skills in microbiology, robotics and computer science. The company addresses all the needs of a laboratory (instrumentation, software, consumables). I2A is recognized for SirScan antibacterial antibiotic testing, SirWeb Bacteriology Validation System and Epidemiology Software. It is also developing a range of reagents around its instruments (antibiotic discs, system for producing inocula, etc.). Its presence is strong in France, where it equips about 75% of hospitals and many private platforms. i2a is the privileged partner of the actors in bacteriology. By always adapting the features of its products to wishes of its users, i2a increases its potential development and innovation in its field of activity, including future technologies. Make a success of the international establishment, this is the objective of i2a for the future years and now !
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 101 – 250
- Estimated revenue: $10K – $50K
- Funding stage: M&A
- Last round: Series Unknown (Nov 2013)
- Website: i2a-diagnostics.com
- Phone: +33 467 504 800
Industries & Categories
Biotechnology, Health Care, Hospital, Manufacturing, Medical Device
Social Profiles
Canonical: https://fsome.com/organization/i2a-sa-549392 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.